---
figid: PMC8066025__viruses-13-00582-g002
figlink: pmc/articles/PMC8066025/figure/viruses-13-00582-f002/
number: Figure 2
caption: Indirect antiviral activities of PARPs through immunomodulation. PARP1 and
  PARP11-induced MARylation of the β-transducin repeat-containing protein (β-TrCP),
  an E3 ubiquitin ligase, promotes interferon alpha/beta receptor 1 (IFNAR1) ubiquitination
  and degradation (1). Concerning RNA virus sensing pathways, PARP13 overexpression
  enhances oligomerization of retinoic acid-inducible gene I (RIG-I) (2), which leads
  to robust activation of downstream antiviral signaling through the interferon regulatory
  factor 3 (IRF3) pathway. On the other hand, PARPs can also downregulate the antiviral
  defenses. PARP7 MARylates TANK-binding kinase 1 (TBK1), decreasing IRF3 activation
  and leading to impaired IFN production (3). Otherwise, PARP12 enhances the signaling
  cascade, leading to NF-κB activation, whereas PARP10 exerts negative feedback on
  this pathway through MARylation of NF-κB essential modulator (NEMO) (4). PARP13
  mediates the degradation of several host IFN mRNAs (5), thereby acting as a negative
  feedback regulator of the interferon response. The PARP9–DTX3L complex is a direct
  binding partner of STAT-1, promoting STAT-1 phosphorylation and nuclear relocalization,
  thereby increasing ISG transcription and leading to amplification of the innate
  immune response (6). PARP14 specifically binds to STAT-6 responsive promoters (7),
  preventing STAT-6-mediated transcription. The inflammatory environment influences
  PARP9–DTX3L and PARP14 immunomodulatory properties. In the presence of the anti-inflammatory
  cytokine IL-4 (8), PARP14 carries out its own MARylation by an autocatalytic process
  that allows binding of STAT-6 and transcription activation. PARP9–DTX3L potentiates
  the response to IFN-γ by enhancing phosphorylation of STAT-1, whereas PARP14, by
  ADP-ribosylating STAT1, decreases the response while increasing phosphorylation
  of STAT-6, thereby promoting the anti-inflammatory response mediated by IL-4. PARP9–DTX3L
  can in turn inhibit MARylation of STAT-1 by PARP14.
pmcid: PMC8066025
papertitle: The Antiviral Activities of Poly-ADP-Ribose Polymerases.
reftext: Mathilde Malgras, et al. Viruses. 2021 Apr;13(4):582.
pmc_ranked_result_index: '19755'
pathway_score: 0.950347
filename: viruses-13-00582-g002.jpg
figtitle: Indirect antiviral activities of PARPs through immunomodulation
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8066025__viruses-13-00582-g002.html
  '@type': Dataset
  description: Indirect antiviral activities of PARPs through immunomodulation. PARP1
    and PARP11-induced MARylation of the β-transducin repeat-containing protein (β-TrCP),
    an E3 ubiquitin ligase, promotes interferon alpha/beta receptor 1 (IFNAR1) ubiquitination
    and degradation (1). Concerning RNA virus sensing pathways, PARP13 overexpression
    enhances oligomerization of retinoic acid-inducible gene I (RIG-I) (2), which
    leads to robust activation of downstream antiviral signaling through the interferon
    regulatory factor 3 (IRF3) pathway. On the other hand, PARPs can also downregulate
    the antiviral defenses. PARP7 MARylates TANK-binding kinase 1 (TBK1), decreasing
    IRF3 activation and leading to impaired IFN production (3). Otherwise, PARP12
    enhances the signaling cascade, leading to NF-κB activation, whereas PARP10 exerts
    negative feedback on this pathway through MARylation of NF-κB essential modulator
    (NEMO) (4). PARP13 mediates the degradation of several host IFN mRNAs (5), thereby
    acting as a negative feedback regulator of the interferon response. The PARP9–DTX3L
    complex is a direct binding partner of STAT-1, promoting STAT-1 phosphorylation
    and nuclear relocalization, thereby increasing ISG transcription and leading to
    amplification of the innate immune response (6). PARP14 specifically binds to
    STAT-6 responsive promoters (7), preventing STAT-6-mediated transcription. The
    inflammatory environment influences PARP9–DTX3L and PARP14 immunomodulatory properties.
    In the presence of the anti-inflammatory cytokine IL-4 (8), PARP14 carries out
    its own MARylation by an autocatalytic process that allows binding of STAT-6 and
    transcription activation. PARP9–DTX3L potentiates the response to IFN-γ by enhancing
    phosphorylation of STAT-1, whereas PARP14, by ADP-ribosylating STAT1, decreases
    the response while increasing phosphorylation of STAT-6, thereby promoting the
    anti-inflammatory response mediated by IL-4. PARP9–DTX3L can in turn inhibit MARylation
    of STAT-1 by PARP14.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFNG
  - DDX58
  - ZC3HAV1
  - MAVS
  - PARP10
  - TANK
  - IKBKG
  - PARP14
  - IKBKB
  - IKBKE
  - CHUK
  - PARP12
  - TIPARP
  - IRF3
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - STAT6
  - PARP9
  - DTX3L
  - IL4
  - PARP11
  - GAST
  - PARP1
  - PARP2
  - PARP3
  - PARP6
  - PARP8
  - PARP15
  - PARP4
  - TNKS
  - PARP16
  - TNKS2
  - CXCL1
  - CXCL2
  - CXCL10
  - CXCL9
  - CXCL6
  - CXCL11
  - CXCL5
  - CXCL14
  - CXCL3
  - CXCL8
  - PF4
  - PPBP
  - CXCL12
  - CXCL13
  - MFAP1
  - IFNA1
  - AMP
genes:
- word: IFNY
  symbol: IFNG
  source: hgnc_symbol
  hgnc_symbol: IFNG
  entrez: '3458'
- word: RIG-I
  symbol: RIG-I
  source: hgnc_alias_symbol
  hgnc_symbol: DDX58
  entrez: '23586'
- word: PARP13
  symbol: PARP13
  source: hgnc_alias_symbol
  hgnc_symbol: ZC3HAV1
  entrez: '56829'
- word: IPS-1
  symbol: IPS-1
  source: hgnc_alias_symbol
  hgnc_symbol: MAVS
  entrez: '57506'
- word: PARP10
  symbol: PARP10
  source: hgnc_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: TANK
  symbol: TANK
  source: hgnc_symbol
  hgnc_symbol: TANK
  entrez: '10010'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: PARP14
  symbol: PARP14
  source: hgnc_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: IKKB
  symbol: IKKB
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: IKKE
  symbol: IKKE
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKE
  entrez: '9641'
- word: IKKA
  symbol: IKKA
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: PARP12
  symbol: PARP12
  source: hgnc_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: PARP7
  symbol: PARP7
  source: hgnc_alias_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: STAT6
  symbol: STAT6
  source: hgnc_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: PARP9
  symbol: PARP9
  source: hgnc_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: DTX3L
  symbol: DTX3L
  source: hgnc_symbol
  hgnc_symbol: DTX3L
  entrez: '151636'
- word: STAT6
  symbol: STAT6
  source: hgnc_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: IL-4
  symbol: IL-4
  source: hgnc_alias_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: PARP11
  symbol: PARP11
  source: hgnc_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: ŠTAT6
  symbol: STAT6
  source: hgnc_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: -NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: -NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: -NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: -NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: -NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: GAS
  symbol: GAS
  source: hgnc_prev_symbol
  hgnc_symbol: GAST
  entrez: '2520'
- word: PARP14
  symbol: PARP14
  source: hgnc_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL1
  entrez: '2919'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL2
  entrez: '2920'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL9
  entrez: '4283'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL6
  entrez: '6372'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL11
  entrez: '6373'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL5
  entrez: '6374'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL14
  entrez: '9547'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL3
  entrez: '2921'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PF4
  entrez: '5196'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PPBP
  entrez: '5473'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL13
  entrez: '10563'
- word: ISG,AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: PARP13
  symbol: PARP13
  source: hgnc_alias_symbol
  hgnc_symbol: ZC3HAV1
  entrez: '56829'
chemicals:
- word: AMP
  source: MESH
  identifier: D000249
diseases: []
---
